Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00323167 · ClinicalTrials.gov registry record
Rare Genetic Disorders of the Breathing Airways
A clinical trial, sponsored by University of North Carolina, Chapel Hill.
- Completed
- Registry status
- 367
- Enrollment target
NCT00323167 is a clinical trial that has completed, run by University of North Carolina, Chapel Hill. The registered enrollment target is 367 participants.
The verdict
NCT00323167 has completed, sponsored by University of North Carolina, Chapel Hill.
- COMPLETED
- Registry status
- 367 participants
- Enrollment target
Study Summary
Mucociliary clearance, in which mucus secretions are cleared from the breathing airways, is the primary defense mechanism for the lungs. Inhaled particles, including microbes that can cause infections, are normally entrapped in mucus on the airway surfaces and then cleared out by the coordinated action of tiny hair-like structures called cilia. Individuals with primary ciliary dyskinesia, variant cystic fibrosis, and pseudohypoaldosteronism have defective mucociliary clearance. The purpose of this study is to collect clinical and genetic information about these three airway diseases to improve current diagnostic procedures.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 367 participants |
| Start Date | 2006-05 |
| Est. Completion | 2012-10 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00323167
The ClinicalTrials.gov registry entry for NCT00323167 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 367 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of North Carolina, Chapel Hill, which has 1,109 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00323167 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00323167 about?
NCT00323167 is a clinical study titled "Rare Genetic Disorders of the Breathing Airways". Mucociliary clearance, in which mucus secretions are cleared from the breathing airways, is the primary defense mechanism for the lungs. Inhaled particles, including microbes that can cause infections, are normally entrapped in mucus on the airway surfaces and then cleared out by the coordinated act...
What is the current status of trial NCT00323167?
This trial is currently completed. The enrollment target is 367 participants. The study started on 2006-05. Estimated completion is 2012-10.
Who is sponsoring clinical trial NCT00323167?
This trial is sponsored by University of North Carolina, Chapel Hill, which has 1,109 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.